AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research abstracts regarding its lead compound, Imofinostat (ABT-301), have ...
The FDA has gained a reputation during the past year for being inconsistently flexible, particularly when it comes to rare ...
The integration of Artificial Intelligence (AI) with multimodal medical data is an emerging field in biomedical informatics, aiming to enhance the accuracy ...
Scientists often encounter translational barriers when moving drug candidates from the laboratory to the clinic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results